Document is current

Any future updates will be listed below

Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib

Crossref DOI link: https://doi.org/10.1007/s00277-015-2518-5

Published Online: 2015-10-13

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark